Sample | Title | Value | Rank |
GSM132917 | SKI-DLCL cells_untreated_24h_1rpt | 3.3 | 20 |
GSM132918 | SKI-DLCL cells_untreated_24h_2rpt | 4 | 24 |
GSM132920 | SKI-DLCL cells_untreated_24h_rpt3 | 2.6 | 20 |
GSM132941 | SKI-DLCL cells_Aplidin 3nM_24h_rpt1 | 3.3 | 20 |
GSM132944 | SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2 | 5.3 | 24 |
GSM132947 | SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3 | 10.8 | 37 |
GSM132949 | SKI-DLCL cells_AraC 20nM_24h_rpt1 | 2.4 | 17 |
GSM132950 | SKI-DLCL cells_AraC 20nM_24h_rpt2 | 1.3 | 10 |
GSM132953 | SKI-DLCL cells_AraC 20nM_24h_rpt3 | 2 | 16 |
GSM132955 | SKI-DLCL cells_Aplidin 1.5nM AraC 5nM_24h_rpt1 | 3.4 | 22 |
GSM132956 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5nM_24h_rpt2 | 1.4 | 12 |
GSM132960 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5.0 nM_24h_rpt3 | 2.3 | 16 |
GSM132760 | SKI-DLCL_tumor_untreated animals | 2.9 | 12 |
GSM132916 | SKI-DLCL_tumor_animals treated with 1mg/kg Aplidin_50mg/kg AraC | 6.7 | 21 |